Interview, Conference Presentation
E62: Elizabeth Holmes verdict, fraud origins & takeaways, navigating "The Great Markdown" & more
- The speaker anticipates Elizabeth Holmes will be found guilty on four counts of fraud, facing a potential 20-year sentence per count served concurrently, which could result in a total term of approximately 15 years after good behavior deductions, significantly impacting investor loss considerations.
- Physical limitations in microfluidics and CRISPR technologies mean that while individual measurements like cholesterol or blood sugar are possible, combining them into a single device with droplet volumes remains physically impossible without decades of breakthroughs.
- The speaker predicts a market correction beginning in November 2021, driven by the Federal Reserve shifting from viewing inflation as transitory to raising rates and shedding assets, which previously caused market convulsions in 2018.
- Trillions of dollars in money market funds are expected to return to the market if valuations for high-growth companies fall from 50–70 times sales to roughly 20 times, potentially creating buy signals.
- Over 900 private unicorns have raised billions at valuations they are unlikely to achieve in the public market within the next three to five years, creating a valuation mismatch where public market haircuts are beginning to spill over into private valuations.
- The speaker asserts that media narratives often failed to conduct due diligence, allowing grandiose stories to build businesses that eventually collapsed, particularly when reporters prioritized the "next Steve Jobs" archetype over factual verification.
- Delaware courts are expected to strictly enforce Section 220, allowing shareholders access to books regarding sales and financial malfeasance, even when companies attempt to hide deal terms or withhold information.
- Significant investment failure is noted in the life sciences hardware sector, with the speaker citing a personal investment of nearly $100 million across three failed ventures due to fundamental physics constraints and the inability to achieve claimed technological milestones.
- Silicon Valley investment firms previously rejected Holmes' due diligence requests, and the speaker claims that the presence of prestigious investors and Walgreens/Safeway contracts served as false endorsements rather than evidence of viability.
- The speaker forecasts a rapid market recovery after an initial Q1 pullback, driven by a slowing rate of change in the 10-year bond yield, suggesting a "snapback" environment where mature, profitable businesses become priced attractively.